Boc-L-MePhg-OH

Boc-L-MePhg-OH is a Boc-protected amino acid building block derived from L-methylphenylglycine, featuring a benzyl-like hydrophobic side chain that supports incorporation into peptide and peptidomimetic sequences. The N-terminus is protected with a tert-butoxycarbonyl (Boc) group, making it a practical intermediate for controlled peptide assembly under Boc-based protection strategies. Its chiral center and bulky aromatic side chain make it valuable for structure-property studies where side-chain sterics and hydrophobic character influence conformation and reactivity in downstream syntheses.

1. Boc-Based Peptide Building Block

Boc-L-MePhg-OH is commonly used as a protected residue for Boc-based peptide synthesis workflows, where the Boc group provides stable N-terminal protection during coupling and deprotection cycles. Researchers developing short peptides, peptide fragments, or peptidomimetic scaffolds rely on L-MePhg incorporation to introduce a hydrophobic, aromatic side chain that can modulate local structure, folding propensity, and physicochemical behavior of the growing sequence. This building block is particularly relevant when the target sequence benefits from sterically defined aromatic substitution while maintaining a protected amino acid format compatible with standard peptide coupling and Boc deprotection practices used in medicinal chemistry and custom peptide manufacturing.

2. Peptidomimetic SAR Intermediates

Boc-L-MePhg-OH serves as a practical intermediate for medicinal chemistry teams performing structure-activity relationship (SAR) exploration with nonstandard amino acid residues. The methylphenylglycine side chain provides a tunable combination of aromatic hydrophobicity and steric bulk that is frequently used to probe how side-chain shape and electronics affect binding-site complementarity and overall peptide-like molecular properties in lead optimization programs. In this context, the Boc-protected format streamlines synthesis of analog libraries by enabling consistent residue incorporation while keeping the amino functionality masked until sequence assembly is complete, supporting efficient generation of closely related analogs for downstream bioassay and physicochemical characterization workflows.

3. Side-Chain Engineering Inhibitor Scaffolds

Boc-L-MePhg-OH is also used in the preparation of peptide-based inhibitor scaffolds and enzyme-interaction probes where side-chain engineering is used to tune presentation of hydrophobic contact points. The L-methylphenylglycine residue introduces an aromatic element that can strengthen noncovalent interactions such as hydrophobic packing and can influence the conformational preferences of peptide segments adjacent to the modified position. Chemical biology groups and peptide medicinal chemistry developers often select this building block when they need a protected, chiral amino acid intermediate that integrates cleanly into multi-residue constructs and supports systematic variation of side-chain substitution patterns for interaction mapping and scaffold refinement.

4. Protected Residue For Library Synthesis

Boc-L-MePhg-OH is frequently selected for parallel or iterative synthesis of protected-residue libraries, where consistent protection and residue identity are essential for reproducible downstream assembly. The Boc-protected amino acid format allows it to be handled as a defined building block in automated or semi-automated peptide workflows used to generate multiple analogs differing at specific positions, especially where aromatic hydrophobic residues are employed to diversify molecular shape. By providing a stable, protected chiral intermediate with a distinct methylphenylglycine side chain, it supports efficient generation of peptide and peptidomimetic series used in analytical method development, reference material preparation, and early-stage structure-property studies.

1. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

2. TMEM16F and dynamins control expansive plasma membrane reservoirs

3. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

4. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active